Drugs with Microchips?

Swiss-based drug manufacturing firm Novartis AG is developing a drug tablet with an embedded microchip to promote greater compliance with drug regimens, Reuters News Service reports.


Swiss-based drug manufacturing firm Novartis AG is developing a drug tablet with an embedded microchip to promote greater compliance with drug regimens, Reuters News Service reports.

The chip is activated by stomach acid and sends a message to a small patch worn on the skin, which then transmits data via a smart phone or other Internet connection to a physician. In essence, the chip confirms to the physician that the patient took the medication at the right time and in the right dose.

The drug firm initially will focus on improving adherence rates with organ transplant patients, and expects to seek regulatory approval within 18 months. For the full Reuters story, click here.

--Joseph Goedert

 

More for you

Loading data for hdm_tax_topic #better-outcomes...